GLTO
Damora Therapeutics, Inc.Healthcare · $34M market cap
Verdict
We can't put a fair value on GLTO right now.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Earnings per share growth—?
Equity per share growth-23.8% a year✗
Sales growth—?
Free cash flow growth—?
Return on invested capital-76.6%✗
Follow GLTO
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
1 of the investors we track holds GLTO. In Q1 2026, 1 opened a position. Who we track
Moves in Q1 2026
New position: Viking Global Investors
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. How the Payback Price works